Global Nasopharyngeal Cancer Drug Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2027

  • ID:PD037511
  • December 2020
  • Value Market Research
                          

The report on the Global Nasopharyngeal Cancer Drug Market gives an estimation of the development of the market based on historical studies and also provides forecasts on the basis of a comprehensive research. The report gives a complete market analysis for the forecasted period from 2021 to 2027. The market is divided into various segments with an in-depth outlook of the competitors and a listing of the profiled key players. The market size in terms of revenue and volume (K Pcs) is calculated and provided for the study period along with the dynamics of the market such as the drivers and the restraints.

Furthermore, the report quantifies the market share held by the major players of the industry and provides an in-depth view of the competitive landscape. This market is classified into different segments with detailed analysis of each with respect to geography for the study period:

  • Base Year: 2020
  • Estimated Year: 2021
  • Forecast Till: 2027

The comprehensive value chain analysis of the market will assist in attaining better product differentiation, along with detailed understanding of the core competency of each activity involved. The market attractiveness analysis provided in the report aptly measures the potential value of the market providing business strategists with the latest growth opportunities. 

The report classifies the market into different segments. These segments are studied in detail incorporating the market estimates and forecasts at regional and country level. The segment analysis is useful in understanding the growth areas and probable opportunities of the market.

The report also covers the complete competitive landscape of the global Nasopharyngeal Cancer Drug market with company profiles of key players such as: 
  • Ambrx Inc
  • arGEN-X BV
  • Atara Biotherapeutics Inc
  • AVEO Pharmaceuticals Inc
  • BeiGene Ltd
  • BioDiem Ltd
  • Biomics Biotechnologies Co Ltd
  • Bristol-Myers Squibb Company
  • CBT Pharmaceuticals Inc
  • Celgene Corp
  • Cell Medica Ltd
  • F. Hoffmann-La Roche Ltd
  • GlaxoSmithKline Plc

The detailed description of each has been included, with information in terms of H.Q, future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other latest industrial developments.

SEGMENTATIONS IN THE REPORT: 

By Type
  • BGBA-317
  • CBT-501
  • Apatinib
  • APG-1387
  • ARGX-110
  • ATA-129
  • Others

By Application
  • Hospital
  • Clinic
  • Others

By Geography:
  • North America (NA) - US, Canada, and Mexico
  • Europe (EU) - UK, Germany, France, Italy, Russia, Spain & Rest of Europe
  • Asia-Pacific (APAC) - China, India, Japan, South Korea, Australia & Rest of APAC
  • Latin America (LA) - Brazil, Argentina, Peru, Chile & Rest of Latin America
  • Middle East and Africa (MEA) - Saudi Arabia, UAE, Israel, South Africa

The Global Nasopharyngeal Cancer Drug Market has been exhibited in detail in the following chapters -
Chapter 1 Nasopharyngeal Cancer Drug Market Preface 
Chapter 2 Executive Summary
Chapter 3 Nasopharyngeal Cancer Drug Industry Analysis
Chapter 4 Nasopharyngeal Cancer Drug Market Value Chain Analysis
Chapter 5 Nasopharyngeal Cancer Drug Market Analysis By Type
Chapter 6 Nasopharyngeal Cancer Drug Market Analysis By Application
Chapter 7 Nasopharyngeal Cancer Drug Market Analysis By Geography
Chapter 8 Competitive Landscape Of Nasopharyngeal Cancer Drug Companies
Chapter 9 Company Profiles Of Nasopharyngeal Cancer Drug Industry

 TABLE OF CONTENTS
 
1 . PREFACE

       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology
 
2 . EXECUTIVE SUMMARY
       2.1. Highlights of Market
       2.2. Global Market Snapshot
 
3 . NASOPHARYNGEAL CANCER DRUG – INDUSTRY ANALYSIS
       3.1. Introduction - Market Dynamics
       3.2. Market Drivers
       3.3. Market Restraints
       3.4. Opportunities
       3.5. Industry Trends
       3.6. Porter’s Five Force Analysis
       3.7. Market Attractiveness Analysis
           3.7.1 By Type
           3.7.2 By Type
           3.7.3 By Region
 
4 . VALUE CHAIN ANALYSIS
       4.1. Value Chain Analysis
       4.2. Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Raw Material Manufactures List
           4.2.3. Price Trend of Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend
 
5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK
       5.1. Impact Analysis of Covid-19 Outbreak
           5.1.1. Direct Impact on Production
           5.1.2. Supply Chain and Market Disruption
           5.1.3. Financial Impact on Firms and Financial Markets
       5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
       5.3. Market: Pre V/S Post COVID-19
       5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic 
       5.5. COVID-19: Micro and Macro Factor Analysis
 
6 . GLOBAL NASOPHARYNGEAL CANCER DRUG MARKET ANALYSIS BY TYPE
       6.1 Overview by Type
       6.2 Historical and Forecast Data
       6.3 Analysis by Type
       6.4 BGBA-317 Market by Regions
       6.6 CBT-501 Market by Regions
       6.5 Apatinib Market by Regions
       6.7 APG-1387 Market by Regions
       6.8 ARGX-110 Market by Regions
       6.9 ATA-129 Market by Regions
       6.10. Others Market by Regions
 
7 . GLOBAL NASOPHARYNGEAL CANCER DRUG MARKET ANALYSIS BY TYPE
       7.1 Overview by Type
       7.2 Historical and Forecast Data
       7.3 Analysis by Type
       7.4 BGBA-317 Market by Regions
       7.5 CBT-501 Market by Regions
       7.6 Apatinib Market by Regions
       7.7 APG-1387 Market by Regions
       7.8 ARGX-110 Market by Regions
       7.9 ATA-129 Market by Regions
       7.10. Others Market by Regions
 
8 . GLOBAL NASOPHARYNGEAL CANCER DRUG MARKET ANALYSIS BY GEOGRAPHY
       8.1. Regional Outlook
       8.2. Introduction
       8.3. North America
           8.3.1. Overview, Historic and Forecast Data 
           8.3.2. North America By Segment
           8.3.3. North America By Country
           8.3.4. United State
           8.3.5. Canada
           8.3.6. Mexico
       8.4. Europe
           8.4.1. Overview, Historic and Forecast Data 
           8.4.2. Europe by Segment
           8.4.3. Europe by Country
           8.4.4. United Kingdom
           8.4.5. France
           8.4.6. Germany
           8.4.7. Italy
           8.4.8. Russia
           8.4.9. Rest Of Europe
       8.5. Asia Pacific
           8.5.1. Overview, Historic and Forecast Data 
           8.5.2. Asia Pacific by Segment
           8.5.3. Asia Pacific by Country
           8.5.4. China
           8.5.5. India
           8.5.6. Japan
           8.5.7. South Korea
           8.5.8. Australia
           8.5.9. Rest Of Asia Pacific
       8.6. Latin America
           8.6.1. Overview, Historic and Forecast Data 
           8.6.2. Latin America by Segment
           8.6.3. Latin America by Country
           8.6.4. Brazil
           8.6.5. Argentina
           8.6.6. Peru
           8.6.7. Chile
           8.6.8. Rest of Latin America
       8.7. Middle East & Africa
           8.7.1. Overview, Historic and Forecast Data 
           8.7.2. Middle East & Africa by Segment
           8.7.3. Middle East & Africa by Country
           8.7.4. Saudi Arabia
           8.7.5. UAE
           8.7.6. Israel
           8.7.7. South Africa
           8.7.8. Rest Of Middle East And Africa
 
9 . COMPETITIVE LANDSCAPE OF THE NASOPHARYNGEAL CANCER DRUG COMPANIES
       9.1. Nasopharyngeal Cancer Drug Market Competition
       9.2. Partnership/Collaboration/Agreement
       9.3. Merger And Acquisitions
       9.4. New Product Launch
       9.5. Other Developments
 
10 . COMPANY PROFILES OF NASOPHARYNGEAL CANCER DRUG INDUSTRY
       10.1. Company Share Analysis
       10.2. Market Concentration Rate
       10.3. Ambrx Inc
           10.3.1. Company Overview
           10.3.2. Financials
           10.3.3. Products
           10.3.4. Recent Developments
       10.4. arGEN-X BV
           10.4.1. Company Overview
           10.4.2. Financials
           10.4.3. Products
           10.4.4. Recent Developments
       10.5. Atara Biotherapeutics Inc
           10.5.1. Company Overview
           10.5.2. Financials
           10.5.3. Products
           10.5.4. Recent Developments
       10.6. AVEO Pharmaceuticals Inc
           10.6.1. Company Overview
           10.6.2. Financials
           10.6.3. Products
           10.6.4. Recent Developments
       10.7. BeiGene Ltd
           10.7.1. Company Overview
           10.7.2. Financials
           10.7.3. Products
           10.7.4. Recent Developments
       10.8. BioDiem Ltd
           10.8.1. Company Overview
           10.8.2. Financials
           10.8.3. Products
           10.8.4. Recent Developments
       10.9. Biomics Biotechnologies Co Ltd
           10.9.1. Company Overview
           10.9.2. Financials
           10.9.3. Products
           10.9.4. Recent Developments
       10.10. Bristol-Myers Squibb Company
           10.10.1. Company Overview
           10.10.2. Financials
           10.10.3. Products
           10.10.4. Recent Developments
       10.11. CBT Pharmaceuticals Inc
           10.11.1. Company Overview
           10.11.2. Financials
           10.11.3. Products
           10.11.4. Recent Developments
       10.12. Celgene Corp
           10.12.1. Company Overview
           10.12.2. Financials
           10.12.3. Products
           10.12.4. Recent Developments
       10.13. Cell Medica Ltd
           10.13.1. Company Overview
           10.13.2. Financials
           10.13.3. Products
           10.13.4. Recent Developments
       10.14. F. Hoffmann-La Roche Ltd
           10.14.1. Company Overview
           10.14.2. Financials
           10.14.3. Products
           10.14.4. Recent Developments
       10.15. GlaxoSmithKline Plc
           10.15.1. Company Overview
           10.15.2. Financials
           10.15.3. Products
           10.15.4. Recent Developments
 
 *Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

 LIST OF TABLES
 

  •  Market Snapshot
  •  Drivers : Impact Analysis
  •  Restraints : Impact Analysis
  •  List of Raw Material
  •  List of Raw Material Manufactures
  •  List of Potential Buyers
  •  COVID-19 Impact Analysis by Production, Import, Export and Demand
  •  Pre V/S Post COVID-19
  •  Estimated Impact Of The Coronavirus (Covid-19) Epidemic
  •  COVID-19: Micro and Macro Factor Analysis
  •  Analysis by Type (K Pcs and USD MN)
  •  BGBA-317 Market by Geography (K Pcs and USD MN)
  •  CBT-501 Market by Geography (K Pcs and USD MN)
  •  Apatinib Market by Geography (K Pcs and USD MN)
  •  APG-1387 Market by Geography (K Pcs and USD MN)
  •  ARGX-110 Market by Geography (K Pcs and USD MN)
  •  ATA-129 Market by Geography (K Pcs and USD MN)
  •  Others Market by Geography (K Pcs and USD MN)
  •  Analysis Market by Type (K Pcs and USD MN)
  •  BGBA-317 Market by Geography (K Pcs and USD MN)
  •  CBT-501 Market by Geography (K Pcs and USD MN)
  •  Apatinib Market by Geography (K Pcs and USD MN)
  •  APG-1387 Market by Geography (K Pcs and USD MN)
  •  ARGX-110 Market by Geography (K Pcs and USD MN)
  •  ATA-129 Market by Geography (K Pcs and USD MN)
  •  Others Market by Geography (K Pcs and USD MN)
  •  Global Nasopharyngeal Cancer Drug Market by Geography (K Pcs and USD MN)
  •  North America Market Analysis (K Pcs and USD MN)
  •  United State Market Analysis (K Pcs and USD MN)
  •  Canada Market Analysis (K Pcs and USD MN)
  •  Mexico Market Analysis (K Pcs and USD MN)
  •  Europe Market Analysis (K Pcs and USD MN)
  •  Europe Market Estimate by Country (K Pcs and USD MN)
  •  United Kingdom Market Analysis (K Pcs and USD MN)
  •  France Market Analysis (K Pcs and USD MN)
  •  Germany Market Analysis (K Pcs and USD MN)
  •  Italy Market Analysis (K Pcs and USD MN)
  •  Russia Market Analysis (K Pcs and USD MN)
  •  Spain Market Analysis (K Pcs and USD MN)
  •  Rest of Europe Market Analysis (K Pcs and USD MN)
  •  Asia Pacific Market Analysis (K Pcs and USD MN)
  •  China Market Analysis (K Pcs and USD MN)
  •  Japan Market Analysis (K Pcs and USD MN)
  •  India Market Analysis (K Pcs and USD MN)
  •  South Korea Market Analysis (K Pcs and USD MN)
  •  Australia Market Analysis (K Pcs and USD MN)
  •  Rest of Asia Pacific Market Analysis (K Pcs and USD MN)
  •  Latin America Market Analysis (K Pcs and USD MN)
  •  Brazil Market Analysis (K Pcs and USD MN)
  •  Argentina Market Analysis (K Pcs and USD MN)
  •  Peru Market Analysis (K Pcs and USD MN)
  •  Chile Market Analysis (K Pcs and USD MN)
  •  Rest of Latin America Market Analysis (K Pcs and USD MN)
  •  Middle East & Africa Market Analysis (K Pcs and USD MN)
  •  Saudi Arabia Market Analysis (K Pcs and USD MN)
  •  UAE Market Analysis (K Pcs and USD MN)
  •  Israel Market Analysis (K Pcs and USD MN)
  •  South Africa Market Analysis (K Pcs and USD MN)
  •  Rest of Middle East and Africa Market Analysis (K Pcs and USD MN)
  •  Partnership/Collaboration/Agreement
  •  Mergers And Acquisiton
 
 LIST OF FIGURES
 
  •  Research Scope of Nasopharyngeal Cancer Drug Report
  •  Market Research Process
  •  Market Research Methodology
  •  Global Nasopharyngeal Cancer Drug Market Size, by Region (K Pcs and USD MN)
  •  Porters Five Forces Analysis
  •  Market Attractiveness Analysis by Type
  •  Market Attractiveness Analysis by Type
  •  Market Attractiveness Analysis by Region
  •  Value Chain Analysis
  •  Global Market Analysis by Type (K Pcs and USD MN)
  •  BGBA-317 Market by Geography (K Pcs and USD MN)
  •  CBT-501 Market by Geography (K Pcs and USD MN)
  •  Apatinib Market by Geography (K Pcs and USD MN)
  •  APG-1387 Market by Geography (K Pcs and USD MN)
  •  ARGX-110 Market by Geography (K Pcs and USD MN)
  •  ATA-129 Market by Geography (K Pcs and USD MN)
  •  Others Market by Geography (K Pcs and USD MN)
  •  Global Market Analysis by Type (K Pcs and USD MN)
  •  BGBA-317 Market by Geography (K Pcs and USD MN)
  •  CBT-501 Market by Geography (K Pcs and USD MN)
  •  Apatinib Market by Geography (K Pcs and USD MN)
  •  APG-1387 Market by Geography (K Pcs and USD MN)
  •  ARGX-110 Market by Geography (K Pcs and USD MN)
  •  ATA-129 Market by Geography (K Pcs and USD MN)
  •  Others Market by Geography (K Pcs and USD MN)
  •  Global Market by Revenue
  •  North America Market by Revenue
  •  Europe Market by Revenue
  •  Asia Pacific Market by Revenue
  •  Latin America Market by Revenue
  •  Middle East & Africa Market by Revenue
  •  Recent Development in Industry
  •  Company Market Share Analysis, 2020
 
 * Kindly note that the above list covers the basic tables and figures of the report and are not limited to the TOC.

Related Categories
Pharmaceuticals
Related Reports
Global Tigecycline Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2027

The report on the Global Tigecycline Market gives an estimation of the development of the market based on historical studies and also provides forecasts  read more..


Global Risperidone Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

The Global Risperidone Market Report is equipped with market data from 2015 to 2025. The report gives a market overview covering key drivers and risks  read more..


Global Caffeine Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2027

The report on the Global Caffeine Market gives an estimation of the development of the market based on historical studies and also provides forecasts on  read more..


Global Rabies Vaccine Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2027

The report on the Global Rabies Vaccine Market gives an estimation of the development of the market based on historical studies and also provides  read more..


Global Radiopharmaceuticals Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2027

The report on the Global Radiopharmaceuticals Market gives an estimation of the development of the market based on historical studies and also provides  read more..


Global Neurorehabilitation System Market Research Report

The report on the Global Neurorehabilitation System Market gives an estimation of the development of the market based on historical studies and also  read more..


Global Molecular Biology Kits And Reagents Market Research Report

The report on the Global Molecular Biology Kits And Reagents Market gives an estimation of the development of the market based on historical studies and  read more..


Global High Acuity Care Information Systems Market Research Report

The report on the Global High Acuity Care Information Systems Market gives an estimation of the development of the market based on historical studies and  read more..


Global Regenerative Medicine Market Research Report

The global regenerative medicine market was estimated to be at ~$4.5 billion in 2013.   A number of factors such as increasing bone related  read more..


Global Skin Cancer Diagnostics Market Research Report

The report on the Global Skin Cancer Diagnostics Market gives an estimation of the development of the market based on historical studies and also  read more..